BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28424276)

  • 21. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
    Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
    J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
    Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
    Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
    Shibata S; Nagase M; Fujita T
    J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model.
    Herrmann A; Tozzo E; Funk J
    Exp Toxicol Pathol; 2012 Jan; 64(1-2):45-9. PubMed ID: 20591637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.
    Toffoli B; Zennaro C; Winkler C; Giordano Attianese GMP; Bernardi S; Carraro M; Gilardi F; Desvergne B
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1154-F1165. PubMed ID: 29488390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between glomerular function and podocyte structure of pre-proteinuria and acute nephrosis in puromycin aminonucleoside-induced rat models: a comparative electron microscopic study.
    Seçkin İ; Uzunalan M; Pekpak M; Köktürk S; Sönmez HA; Güngör ZB; Demirkiran ÖD; Saygi Hİ; Yaprak Saraç E
    Rom J Morphol Embryol; 2017; 58(3):823-830. PubMed ID: 29250660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria.
    Ma J; Zhang B; Liu S; Xie S; Yang Y; Ma J; Deng Y; Wang W; Xu L; Li R; Zhang L; Yu C; Shi W
    PLoS One; 2013; 8(5):e64912. PubMed ID: 23741418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases.
    Beeken M; Lindenmeyer MT; Blattner SM; Radón V; Oh J; Meyer TN; Hildebrand D; Schlüter H; Reinicke AT; Knop JH; Vivekanandan-Giri A; Münster S; Sachs M; Wiech T; Pennathur S; Cohen CD; Kretzler M; Stahl RA; Meyer-Schwesinger C
    J Am Soc Nephrol; 2014 Nov; 25(11):2511-25. PubMed ID: 24722446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMPK mediates regulation of glomerular volume and podocyte survival.
    Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
    Raij L; Tian R; Wong JS; He JC; Campbell KN
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rac1 activation in podocytes induces the spectrum of nephrotic syndrome.
    Robins R; Baldwin C; Aoudjit L; Côté JF; Gupta IR; Takano T
    Kidney Int; 2017 Aug; 92(2):349-364. PubMed ID: 28483380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
    Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
    Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glial cell line-derived neurotrophic factor and its receptor ret is a novel ligand-receptor complex critical for survival response during podocyte injury.
    Tsui CC; Shankland SJ; Pierchala BA
    J Am Soc Nephrol; 2006 Jun; 17(6):1543-52. PubMed ID: 16672314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis.
    Asao R; Seki T; Takagi M; Yamada H; Kodama F; Hosoe-Nagai Y; Tanaka E; Trejo JAO; Yamamoto-Nonaka K; Sasaki Y; Hidaka T; Ueno T; Yanagita M; Suzuki Y; Tomino Y; Asanuma K
    Sci Rep; 2018 Mar; 8(1):5061. PubMed ID: 29567961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.
    Matsui I; Hamano T; Tomida K; Inoue K; Takabatake Y; Nagasawa Y; Kawada N; Ito T; Kawachi H; Rakugi H; Imai E; Isaka Y
    Nephrol Dial Transplant; 2009 Aug; 24(8):2354-61. PubMed ID: 19297354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration.
    Ren J; Xu Y; Lu X; Wang L; Ide S; Hall G; Souma T; Privratsky JR; Spurney RF; Crowley SD
    JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34369383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
    Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.